Plain-English translation of NCT07077239 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing stereotactic body radiotherapy (SBRT)—a focused, high-dose radiation treatment that uses real-time imaging to adapt and adjust during each session. The study wants to see if this adaptive technology can treat prostate cancer that has returned or requires additional treatment after surgery, while reducing damage to nearby healthy tissues like the bladder and bowel.
After prostate surgery, some men need additional radiation therapy because their cancer shows signs of recurrence or high-risk features. Standard radiation can sometimes damage the bladder and bowel, causing side effects like urinary or bowel problems. This trial is testing whether newer, more precise radiation technology can be just as effective while causing fewer of these side effects.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive stereotactic body radiotherapy—a specialized radiation treatment delivered over a short course of sessions. Before and during your treatment, the medical team will use MRI or CT imaging to precisely target the prostate bed and lymph nodes, adjusting the radiation in real time to minimize exposure to nearby bladder and bowel tissue. You will be asked to complete quality-of-life surveys measuring urinary and bowel side effects at various time points, with follow-up assessments continuing for at least 24 months after your treatment ends.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
United States
Sponsor
Jonsson Comprehensive Cancer Center
Enrollment target
~200 participants
Started
July 2025
Primary completion
August 2035
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
CHRISTY PALODICHUK
University of California at Los Angeles
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.